|
|
 |
|
Viewing report
|
|
|
|
Enhance Biotech Inc.-Financial Company Report
Life Science Analytics, March 2008, Pages: 21
Enhance Biotech Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends, market related data including relative strength, valuation and revenues. The report also includes earnings and earnings per share, margin and return ratios, financial strength, growth ratios, day’s sales outstanding, day’s outstanding inventory, cash and short-term investments per share and total common shares outstanding. Finally the report includes quarterly book value per share vs. share price. Much of the information contained in the report is included in both tabular and graphic formats.
Financial Reports deliver key sophisticated analytical ratios and performance analyses for public biomedical companies. Each report provides an in depth virtual snapshot of a company, enabling the user to better understand its financial position.
Scope of the reports
Each Financial Report provides extensive information on a company’s financial health including:
Company contact information and business overview
Stock performance history
Dividend history
Price and volume figures, including key price ratios relative to earnings, book value ratios and comparisons, sales, cash flow, and share price
Historical market-related data including relative strength, valuation, common and diluted shares are presented in graphical form.
Each report provides extensive data on return ratios, financial strength, and growth ratios. Convenient historical tables on quarterly and annual income statements, balance sheets and cash flow statements are also included.
Key benefits
Data in each Financial Report is presented in both tabular and graphical format providing the user with an efficient assessment of a company’s historical performance.
Stay ahead of the competition by accessing the latest financial intelligence.
Sophisticated financial analysis ratios provide a quick insight into management’s effectiveness and the company’s ability to meet its short-term obligations.
Customers who bought this item also bought
Enhance Biotech Inc.-Therapeutic Competitors
Enhance Biotech Inc.-Detailed Product Pipeline
Enhance Biotech Inc.-Deals & Alliances Report
Biotech 2009-Life Sciences: Navigating the Sea Change
Trinity Biotech Plc - Financial and Strategic Analysis Review
GPC Biotech AG - Financial and Strategic Analysis Review
Strategic Alliances in World Pharma and Biotech Markets
The Asia-Pacific Biotechnology Sectors : A Company and Industry Analysis (June 2006)
The North America Biotechnology Sectors : A Company and Industry Analysis (August 2005)
UAE Pharmaceuticals and Healthcare Report Q1 2008
Dermatology Skin Infections or Dermatosis or Skin Itching
The North America Biotechnology Sectors : A Company and Industry Analysis (August 2006)
|
|
|
|
